- Pharmaceutical companies
- Europe
- Italy
- Alexion Pharmaceuticals
Alexion Pharmaceuticals in Italy
Web: https://alexion.com/worldwide/Italy
Address:
-
Alexion Pharma Italy s.r.l.
Viale Decumano 39, 20157 Milan
Phone: +39 02 7767 9211
Fax: +39 (02) 77 679 212
Other Alexion Pharmaceuticals's locations around the world
Clinical Trials sponsored by Alexion Pharmaceuticals
-
Alexion PharmaceuticalsЗавершенныйПароксизмальная ночная гемоглобинурияСоединенное Королевство
-
Alexion PharmaceuticalsЗавершенный
-
Alexion PharmaceuticalsЗавершенныйПароксизмальная ночная гемоглобинурия | ПНХКорея, Республика, Канада, Франция, Германия, Испания, Тайвань, Соединенное Королевство
-
Alexion PharmaceuticalsЗавершенный
-
Alexion PharmaceuticalsЗавершенныйИсследование эффективности и безопасности WTX101 (ALXN1840) у взрослых пациентов с болезнью ВильсонаБолезнь ВильсонаСоединенные Штаты, Германия, Австрия, Польша, Соединенное Королевство
-
Alexion PharmaceuticalsЗавершенный
-
Alexion PharmaceuticalsЗавершенныйДефицит лизосомальной кислой липазыФранция, Польша, Соединенное Королевство, Испания, Мексика, Турция, Япония, Австралия, Российская Федерация, Соединенные Штаты, Германия, Италия, Чехия, Аргентина, Хорватия
-
Alexion PharmaceuticalsОтозван
-
Alexion PharmaceuticalsЗавершенныйРефрактерная генерализованная миастения грависИталия, Соединенное Королевство, Испания, Бельгия, Турция, Япония, Соединенные Штаты, Нидерланды, Корея, Республика, Аргентина, Венгрия, Швеция, Дания, Бразилия, Чехия, Финляндия, Канада
About Alexion Pharmaceuticals
People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. To transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. And we’re making real progress, every day. We continue to deepen our understanding of rare disease, which began with our pioneering work in complement biology. This knowledge allows us to innovate and evolve into new areas, where there is great unmet need and opportunity to help patients and families fully live their best lives. We’ve delivered transformative medicines for people with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), generalized Myasthenia Gravis (gMG), hypophosphatasia (HPP), and lysosomal acid lipase deficiency (LAL-D). We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day.